Mar 26, 2012, 4:30 p.m. by Jack Gauldie
The pathobiology underlying lung fibrosis and drug development is reviewed.
Jack Gauldie, a professor of pathology and molecular medicine, reviews the pathobiology underlying lung fibrosis and explains how these pathogenetic concepts are translated into drug development.
Please complete our feedback form.